China Universal Asset Management Company’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
RG
CDDEC
BTCPP
AAMU
ISS
AIM
China Universal Asset Management Company's AZN Position: Q2 2026 in Review
China Universal Asset Management Company sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 25,600 shares — an estimated $5.05M sold.
China Universal Asset Management Company first reported a position in AZN in Q3 2022 and held it in 15 quarters. The position peaked at $12.5M in Q4 2025. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- China Universal Asset Management Company reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
- China Universal Asset Management Company sold 25,600 AstraZeneca shares in Q2 2026, an estimated $5.05M.
- China Universal Asset Management Company first reported a position in AstraZeneca in Q3 2022 and held it in 15 quarters.
- China Universal Asset Management Company's AstraZeneca position peaked at $12.5M in Q4 2025.
- 655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.